FDA panel backs Merck’s antiviral COVID pill

COVID. Almost 4 mutated strands, 3 vaccines, 2 years, & 1 pill later. Maybe, this is a solution people can agree with. But, for some, it may still be a hard pill to swallow.

An FDA advisory panel on Tuesday voted 13-10 to endorse an antiviral pill developed by Merck and Ridgeback Biotherapeutics to treat adults at high risk of becoming severely ill from COVID-19, despite concerns over its safety and (read full story)

Medical Test Kits: (Click here)